A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development.
Biomater Transl. 2021 Mar 28;2(1):30-42. doi: 10.3877/cma.j.issn.2096-112X.2021.01.005. eCollection 2021.
Biomater Transl. 2021.
PMID: 35837251
Free PMC article.
Review.